Adding to this, mice heterozygous for TAZ show a remarkable resilience against bleomycin-induced pulmonary fibrosis, possibly due to reduced levels of CCN2 (CTGF), one of the YAP and TAZ target genes (110). The gene discussed is CCN2; the disease is pulmonary fibrosis.